Seres Therapeutics, Inc. (MCRB) Capital expenditures 2016–2025
Seres Therapeutics, Inc. (MCRB) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$252,000FY2025 · since FY2016: $21.5M → $252,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $252,000 | -33.7% |
| FY2024 | $380,000 | -95.2% |
| FY2023 | $8.0M | -18.8% |
| FY2022 | $9.8M | +2.7% |
| FY2021 | $9.6M | +1518.6% |
| FY2020 | $591,000 | -41.0% |
| FY2019 | $1.0M | -48.3% |
| FY2018 | $1.9M | -58.6% |
| FY2017 | $4.7M | -78.2% |
| FY2016 | $21.5M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice